Volume 128, Issue 3, Pages 1128-1135 (September 2005) Effects of 24 Weeks of Lansoprazole Therapy on Asthma Symptoms, Exacerbations, Quality of Life, and Pulmonary Function in Adult Asthmatic Patients With Acid Reflux Symptoms Littner Michael R. , MD, Leung Felix W. , MD, Ballard E. David , MD, Huang Bidan , PhD, Samra Nina K. , MS CHEST Volume 128, Issue 3, Pages 1128-1135 (September 2005) DOI: 10.1378/chest.128.3.1128 Copyright © 2005 The American College of Chest Physicians Terms and Conditions
Figure 1 Study outline and disposition of patients. CHEST 2005 128, 1128-1135DOI: (10.1378/chest.128.3.1128) Copyright © 2005 The American College of Chest Physicians Terms and Conditions
Figure 2 Percentage of patients with at least one exacerbation or at least one moderate-to-severe exacerbation of asthma with lansoprazole, 30 mg bid, or placebo bid. Mod to Severe Exacerbation = moderate-to-severe exacerbation, defined as an exacerbation requiring oral-corticosteroid treatment. For the number of patients in each group, see Table 1. CHEST 2005 128, 1128-1135DOI: (10.1378/chest.128.3.1128) Copyright © 2005 The American College of Chest Physicians Terms and Conditions
Figure 3 Time to the occurrence of the first exacerbation in patients receiving lansoprazole, 30 mg bid, or placebo bid. For the number of patients in each group, see Table 1. CHEST 2005 128, 1128-1135DOI: (10.1378/chest.128.3.1128) Copyright © 2005 The American College of Chest Physicians Terms and Conditions